粥腫切除術及び血栓摘出術用デバイスの世界市場

◆英語タイトル:Global Atherectomy and Thrombectomy Devices Market 2015-2019
◆商品コード:IRTNTR6543
◆発行会社(調査会社):Technavio
◆発行日:2015年8月19日
◆ページ数:81
◆レポート言語:英語
◆レポート形式:pdf
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、粥腫切除術及び血栓摘出術用デバイスの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、粥腫切除術及び血栓摘出術用デバイスの世界市場規模及び予測、製品別分析、地域別分析、購買基準、市場の成長要因、市場の課題、医療費償還シナリオ、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

About Atherectomy and Thrombectomy Devices
Atherectomy devices are used to remove atherosclerotic plaques to clear blocked blood vessels. Atherosclerotic plaques are deposits of fats, calcium, or other substances inside the blood vessels. It is an endovascular procedure for the treatment of PAD and CAD. PVD refers to damaged or blocked peripheral blood vessels that supply blood to the arms, legs, and organs other than brain and heart. PAD, which is PVD of the arteries, is known to increase the risk of stroke and heart attack by up to six times. CAD is a condition of narrowing of arteries that supply blood to heart muscles. Stents, balloon catheters, atherectomy devices are used in endovascular procedures to treat PVD. Thrombectomy devices are used to surgically remove thrombi (clot) from the blood vessels during the treatment of DVT. DVT is the blood clot formed in deep veins in the body, mainly in legs. The risk of developing these vascular diseases increases with age. Diabetes, high blood pressure, obesity, and smoking are other risk factors for these diseases.

Technavio’s analysts forecast the global atherectomy and thrombectomy market to grow at a CAGR of 6.25% over the period 2014-2019.

[Covered in this Report]
The report includes the present scenario and the growth prospects of the global atherectomy and thrombectomy devices market for the period 2015-2019. The market can be segmented into two divisions: atherectomy devices and thrombectomy devices.

Technavio’s report, Global Atherectomy and Thrombectomy Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global atherectomy and thrombectomy devices market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• Boston Scientific Group
• Cardiovascular Systems
• Medtronic
• Spectranetics

[Other Prominent Vendors]
• Argon Medical Devices
• C.R. Bard
• Cod Man Neuro (DePuy Orthopaedics)
• Cook Medical
• Edwards Lifesciences
• IDEV Technologies (subsidiary of Abbott Vascular)
• Lake Region Medical
• NexGen Medical Systems
• Reverse Medical
• St. Jude Medical
• Teleflex Medical
• Volcano (acquired by Philips)

[Market Driver]
• Growing Prevalence of PAD and DVT
• For a full, detailed list, view our report

[Market Challenge]
• Product Recalls
• For a full, detailed list, view our report

[Market Trend]
• Growing Number of Acquisitions
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【レポートの目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
03.2.1 Atherectomy Products
03.2.2 Thrombectomy Products

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Global Atherectomy and Thrombectomy Devices Market
06.1 Market Overview
06.1.1 Market Size and Forecast

07.Global Atherectomy and Thrombectomy Market Segmentation by Product Type
07.1 Atherectomy Devices
07.2 Thrombectomy Devices
07.3 Five Forces Analysis

08.Global Atherectomy Devices Market
08.1 Market Overview
08.1.1 Market Size and Forecast
08.2 Market Segmentation by Procedure Type

09.Global Thrombectomy Devices Market
09.1 Market Overview
09.1.1 Market Size and Forecast
09.2 Market Segmentation by Product Type
09.3 Market Segmentation by Procedure Type

10.Reimbursement Scenario of Atherectomy and Thrombectomy Devices
10.1 Reimbursement Scenario in Americas
10.2 Reimbursement Scenario in EMEA
10.3 Reimbursement Scenario in APAC

11.Geographical Segmentation
11.1 Atherectomy and Thrombectomy Devices Market in Americas
11.1.1 Market Size and Forecast
11.2 Atherectomy and Thrombectomy Devices Market in EMEA
11.2.1 Market Size and Forecast
11.3 Atherectomy and Thrombectomy Devices Market in APAC
11.3.1 Market Size and Forecast

12.Buying Criteria

13.Market Growth Drivers

14.Drivers and their Impact

15.Market Challenges

16.Impact of Drivers and Challenges

17.Market Trends

18.Trends and their Impact

19.Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Vendor Analysis 2015
19.2.1 Boston Scientific Group
19.2.2 Cardiovascular Systems
19.2.3 Medtronic
19.2.4 Spectranetics
19.2.5 Other Prominent Vendors

20.Key Vendor Analysis
20.1 Boston Scientific Group
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation
20.1.4 Business Strategy
20.1.5 Business Segmentation by Revenue
20.1.6 Business Segmentation by Revenue 2012 and 2013
20.1.7 Geographical Segmentation by Revenue
20.1.8 Key Developments
20.1.9 SWOT Analysis
20.2 Cardiovascular Systems
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Product Segmentation Based on Therapy Areas
20.2.4 Business Strategy
20.2.5 Recent Developments
20.2.6 SWOT Analysis
20.3 Medtronic
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation by Revenue 2013
20.3.4 Business Segmentation by Revenue 2012 and 2013
20.3.5 Geographical Segmentation by Revenue 2013
20.3.6 Business Strategy
20.3.7 Recent Developments
20.3.8 SWOT Analysis
20.4 Spectranetics
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation 2014
20.4.4 Business Segmentation by Revenue 2013 and 2014
20.4.5 Geographical Segmentation by Revenue 2014
20.4.6 Business Strategy
20.4.7 Recent Developments
20.4.8 SWOT Analysis

21.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Global Atherectomy and Thrombectomy Devices Market 2014-2019 ($ million)
Exhibit 3: Global Atherectomy and Thrombectomy Devices Market: Segmentation by Product Type
Exhibit 4: Global Atherectomy and Thrombectomy Devices Market 2014
Exhibit 5: Global Atherectomy Devices Market 2014-2019 ($ million)
Exhibit 6: Global Atherectomy Devices Market: Segmentation by Procedure Type
Exhibit 7: Global Thrombectomy Devices Market 2014-2019 ($ million)
Exhibit 8: Global Thrombectomy Devices Market: Segmentation by Product Type
Exhibit 9: Segmentation of Global Thrombectomy Devices Market by Procedure Type
Exhibit 10: Global Atherectomy and Thrombectomy Devices Market 2014-2019
Exhibit 11: Global Atherectomy and Thrombectomy Devices Market 2014-2019($ million)
Exhibit 12: Reimbursement for Atherectomy (Medicare)
Exhibit 13: Reimbursement for Thrombectomy (Medicare)
Exhibit 14: Geographical Segmentation of Global Atherectomy and Thrombectomy Devices Market 2014
Exhibit 15: Atherectomy and Thrombectomy Devices Market in Americas 2014-2019 ($ million)
Exhibit 16: Atherectomy and Thrombectomy Devices Market in EMEA 2014-2019 ($ million)
Exhibit 17: Atherectomy and Thrombectomy Devices Market in APAC 2014-2019 ($ million)
Exhibit 18: Geographical Segmentation of Global Atherectomy and Thrombectomy Devices Market 2014-2019
Exhibit 19: Geographical Segmentation of Global Atherectomy and Thrombectomy Devices Market 2014-2019 ($ million)
Exhibit 20: Key Takeaways: Boston Scientific Group
Exhibit 21: Key Takeaways: Cardiovascular Systems
Exhibit 22: Key Takeaways: Medtronic
Exhibit 23: Key Takeaways: Spectranetics
Exhibit 24: Boston Scientific: Business Segmentation 2013
Exhibit 25: Boston Scientific: Business Segmentation by Revenue 2013
Exhibit 26: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 27: Boston Scientific: Geographical Segmentation by Revenue 2012 and 2013 2013
Exhibit 28: Cardiovascular Systems: Product Segmentation Based on Therapy Areas
Exhibit 29: Medtronic: Business Segmentation by Revenue 2013
Exhibit 30: Medtronic: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 31: Medtronic: Geographical Segmentation by Revenue 2013
Exhibit 32: Spectranetics: Business Segmentation 2014
Exhibit 33: Spectranetics: Business Segmentation by Revenue 2013 and 2014 ($ million)
Exhibit 34: Spectranetics: Geographical Segmentation by Revenue 2014



【掲載企業】

Boston Scientific Group, Cardiovascular Systems, Medtronic, Spectranetics, Argon Medical Devices, C.R. Bard, Cod Man Neuro (DePuy Orthopaedics), Cook Medical, Edwards Lifesciences, IDEV Technologies (subsidiary of Abbott Vascular), Lake Region Medical, NexGen Medical Systems, Reverse Medical, St. Jude Medical, Teleflex Medical, Volcano (acquired by Philips)

【レポートのキーワード】

粥腫切除術(アテレクトミー)用デバイス、血栓摘出術用デバイス、医療機器、血管、PAD、治療、疾患

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[粥腫切除術及び血栓摘出術用デバイスの世界市場]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。H&I文字はH&Iグローバルリサーチ株式会社の商標(登録第5783645号)です。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。
※当サイトでは2016年05月30日現在 190,440 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆